Allogene Therapeutics ALLO
NASDAQ ALLO
$1.50 -0.04 (-2.60%)
At close: Oct 2, 2026 · 4:00 PM EDT

Allogene Therapeutics (ALLO) Change in Accured Expenses (2018 - 2026)

Updated

Allogene Therapeutics' Change in Accured Expenses came in at $2.28 million for Q2 2026, up 31.4% from $1.74 million a year earlier.

Analysis

Allogene Therapeutics (ALLO) Change in Accured Expenses (2018 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Allogene Therapeutics reported Change in Accured Expenses of -$1.85 million; for FY2025, it was -$2.52 million.

  • Going back by year, Change in Accured Expenses was -$1.26 million in FY2024, -$6.82 million in FY2023, $1.75 million in FY2022 (-52.1%) and $3.65 million in FY2021 (-80.5%).
  • The Q2 2026 figure represents the highest quarterly Change in Accured Expenses since Q4 2024.
  • Business Quant data shows ALLO's Change in Accured Expenses at -$5.1 million (Q1 2026), -$118,000 (Q4 2025) and $1.09 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 2.96 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -251.00 Mn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 901.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 338.00 Mn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Allogene Therapeutics 518.02 Mn 518.02 Mn - 2.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.28 Mn
Mar 31, 2026 -5.10 Mn
Dec 31, 2025 -118,000.00
Sep 30, 2025 1.09 Mn
Jun 30, 2025 1.74 Mn
Mar 31, 2025 -5.22 Mn
Dec 31, 2024 2.88 Mn
Sep 30, 2024 2.53 Mn
Jun 30, 2024 -980,000.00
Mar 31, 2024 -5.69 Mn
Dec 31, 2023 286,000.00
Sep 30, 2023 -12.72 Mn
Jun 30, 2023 -79,000.00
Mar 31, 2023 5.69 Mn
Dec 31, 2022 3.14 Mn
Sep 30, 2022 1.95 Mn
Jun 30, 2022 5.71 Mn
Mar 31, 2022 -9.05 Mn
Dec 31, 2021 -2.77 Mn
Sep 30, 2021 8.89 Mn
API Access

Allogene Therapeutics Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=ALLO&period=max&api_key=YOUR_API_KEY